These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. CXCR6 protects from inflammation and fibrosis in NEMO Liepelt A; Wehr A; Kohlhepp M; Mossanen JC; Kreggenwinkel K; Denecke B; Costa IG; Luedde T; Trautwein C; Tacke F Biochim Biophys Acta Mol Basis Dis; 2019 Feb; 1865(2):391-402. PubMed ID: 30476545 [TBL] [Abstract][Full Text] [Related]
3. Chemokine receptor CXCR6-dependent hepatic NK T Cell accumulation promotes inflammation and liver fibrosis. Wehr A; Baeck C; Heymann F; Niemietz PM; Hammerich L; Martin C; Zimmermann HW; Pack O; Gassler N; Hittatiya K; Ludwig A; Luedde T; Trautwein C; Tacke F J Immunol; 2013 May; 190(10):5226-36. PubMed ID: 23596313 [TBL] [Abstract][Full Text] [Related]
4. Roles of CCR2 and CCR5 for Hepatic Macrophage Polarization in Mice With Liver Parenchymal Cell-Specific NEMO Deletion. Bartneck M; Koppe C; Fech V; Warzecha KT; Kohlhepp M; Huss S; Weiskirchen R; Trautwein C; Luedde T; Tacke F Cell Mol Gastroenterol Hepatol; 2021; 11(2):327-347. PubMed ID: 32896623 [TBL] [Abstract][Full Text] [Related]
5. NADPH Oxidase 1 in Liver Macrophages Promotes Inflammation and Tumor Development in Mice. Liang S; Ma HY; Zhong Z; Dhar D; Liu X; Xu J; Koyama Y; Nishio T; Karin D; Karin G; Mccubbin R; Zhang C; Hu R; Yang G; Chen L; Ganguly S; Lan T; Karin M; Kisseleva T; Brenner DA Gastroenterology; 2019 Mar; 156(4):1156-1172.e6. PubMed ID: 30445007 [TBL] [Abstract][Full Text] [Related]
6. Death receptor-independent FADD signalling triggers hepatitis and hepatocellular carcinoma in mice with liver parenchymal cell-specific NEMO knockout. Ehlken H; Krishna-Subramanian S; Ochoa-Callejero L; Kondylis V; Nadi NE; Straub BK; Schirmacher P; Walczak H; Kollias G; Pasparakis M Cell Death Differ; 2014 Nov; 21(11):1721-32. PubMed ID: 24971483 [TBL] [Abstract][Full Text] [Related]
7. CXCR6 deficiency ameliorates ischemia-reperfusion injury by reducing the recruitment and cytokine production of hepatic NKT cells in a mouse model of non-alcoholic fatty liver disease. Zhu H; Zhang Q; Chen G Int Immunopharmacol; 2019 Jul; 72():224-234. PubMed ID: 31002999 [TBL] [Abstract][Full Text] [Related]
9. The chemokine receptor CCR10 promotes inflammation-driven hepatocarcinogenesis via PI3K/Akt pathway activation. Wu Q; Chen JX; Chen Y; Cai LL; Wang XZ; Guo WH; Zheng JF Cell Death Dis; 2018 Feb; 9(2):232. PubMed ID: 29445190 [TBL] [Abstract][Full Text] [Related]
10. A critical role for IFN regulatory factor 1 in NKT cell-mediated liver injury induced by alpha-galactosylceramide. Cao Z; Dhupar R; Cai C; Li P; Billiar TR; Geller DA J Immunol; 2010 Aug; 185(4):2536-43. PubMed ID: 20624945 [TBL] [Abstract][Full Text] [Related]
11. Loss of immunity-supported senescence enhances susceptibility to hepatocellular carcinogenesis and progression in Toll-like receptor 2-deficient mice. Lin H; Yan J; Wang Z; Hua F; Yu J; Sun W; Li K; Liu H; Yang H; Lv Q; Xue J; Hu ZW Hepatology; 2013 Jan; 57(1):171-82. PubMed ID: 22859216 [TBL] [Abstract][Full Text] [Related]
12. Critical role for the chemokine receptor CXCR6 in homeostasis and activation of CD1d-restricted NKT cells. Germanov E; Veinotte L; Cullen R; Chamberlain E; Butcher EC; Johnston B J Immunol; 2008 Jul; 181(1):81-91. PubMed ID: 18566372 [TBL] [Abstract][Full Text] [Related]
13. An Immune Gene Expression Signature Associated With Development of Human Hepatocellular Carcinoma Identifies Mice That Respond to Chemopreventive Agents. Moeini A; Torrecilla S; Tovar V; Montironi C; Andreu-Oller C; Peix J; Higuera M; Pfister D; Ramadori P; Pinyol R; Solé M; Heikenwälder M; Friedman SL; Sia D; Llovet JM Gastroenterology; 2019 Nov; 157(5):1383-1397.e11. PubMed ID: 31344396 [TBL] [Abstract][Full Text] [Related]
14. Enhanced tumor metastasis in response to blockade of the chemokine receptor CXCR6 is overcome by NKT cell activation. Cullen R; Germanov E; Shimaoka T; Johnston B J Immunol; 2009 Nov; 183(9):5807-15. PubMed ID: 19812206 [TBL] [Abstract][Full Text] [Related]
16. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells. Xiang J; Zhang N; Sun H; Su L; Zhang C; Xu H; Feng J; Wang M; Chen J; Liu L; Shan J; Shen J; Yang Z; Wang G; Zhou H; Prieto J; Ávila MA; Liu C; Qian C Gastroenterology; 2020 Feb; 158(3):664-678.e24. PubMed ID: 31678303 [TBL] [Abstract][Full Text] [Related]
17. The Role of Indoleamine 2,3-Dioxygenase in Diethylnitrosamine-Induced Liver Carcinogenesis. Shibata Y; Hara T; Nagano J; Nakamura N; Ohno T; Ninomiya S; Ito H; Tanaka T; Saito K; Seishima M; Shimizu M; Moriwaki H; Tsurumi H PLoS One; 2016; 11(1):e0146279. PubMed ID: 26727596 [TBL] [Abstract][Full Text] [Related]
18. Activating immunity in the liver. I. Liver dendritic cells (but not hepatocytes) are potent activators of IFN-gamma release by liver NKT cells. Trobonjaca Z; Leithäuser F; Möller P; Schirmbeck R; Reimann J J Immunol; 2001 Aug; 167(3):1413-22. PubMed ID: 11466360 [TBL] [Abstract][Full Text] [Related]
20. Li T; Lin X; Shen B; Zhang W; Liu Y; Liu H; Wang Y; Zheng L; Zhi F Front Immunol; 2022; 13():1047570. PubMed ID: 36531991 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]